The specificity and molecular basis of α1-adrenoceptor and CXCR chemokine receptor dimerization

Journal of Molecular Neuroscience

Volumn 26, Issue 2-3, 2005, Pages 161-168

  Milligan, Graeme ^a   Wilson, Shirley ^a   López Gimenez, Juan F ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Chemokine; Dimerization; Endoplasmic reticulum; G protein coupled receptor; Resonance energy transfer

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR2; G PROTEIN COUPLED RECEPTOR; LIGAND;

BIOLUMINESCENCE RESONANCE ENERGY TRANSFER; CONFERENCE PAPER; DIMERIZATION; ENDOPLASMIC RETICULUM; FLUORESCENCE ANALYSIS; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MOLECULAR INTERACTION; MOLECULAR MODEL; OLIGOMERIZATION; PROTEIN FAMILY; RECEPTOR AFFINITY; RECEPTOR SENSITIVITY;

EID: 25844464220     PISSN: 08958696     EISSN: None     Source Type: Journal    
DOI: 10.1385/JMN:26:2-3:161     Document Type: Conference Paper

References (29)

1. Angers S., Salahpour A., and Bouvier M. (2002) Dimerization: an emerging concept for G protein-coupled receptor ontogeny and function. Annu. Rev. Pharmacol. Toxicol. 42, 409-435.
2. Baneres J. L. and Parello J. (2003) Structure-based analysis of GPCR function: evidence for a novel pentameric assembly between the dimeric leukotriene B4 receptor BLT1 and the G-protein. J. Mol. Biol. 329, 815-829.
3. Brady A. E. and Limbird L. E. (2002) G protein-coupled receptor interacting proteins: emerging roles in localization and signal transduction. Cell. Signal. 14, 297-309.
4. 1b-adrenoceptor. Mol. Pharmacol. 66, 1123-1137.
5. Carrillo J. J., Pediani J., and Milligan G. (2003) Dimers of class A G protein-coupled receptors function via agonist-mediated trans-activation of associated G proteins. J. Biol. Chem. 278, 42578-42587.
6. 3H]prazosin binding and cellular trafficking of native human alpha1A-adrenoceptors. Biochem. J. 343, 231-239.
7. George S. R., O'Dowd B. F., and Lee S. P. (2002) G-protein-coupled receptor oligomerization and its potential for drug discovery. Nat. Rev. Drug Discovery 1, 808-820.
8. Guo W., Shi L., and Javitch J. A. (2003) The fourth transmembrane segment forms the interface of the dopamine D2 receptor homodimer. J. Biol. Chem. 278, 4385-4388.
9. Hakak Y., Shrestha D., Goegel M. C., Behan D. P., and Chalmers D. T. (2003) Global analysis of G-protein-coupled receptor signaling in human tissues. FEBS Lett. 550, 11-17.
10. Hernanz-Falcon P., Rodriguez-Frade J. M., Serrano A., Juan D., del Sol A., Soriano S. F., et al. (2004) Identification of amino acid residues crucial for chemokine receptor dimerization. Nat. Immunol. 5, 216-223.
11. Klco J. M., Lassere T. B., and Baranski T. J. (2003) C5a receptor oligomerization. I. Disulfide trapping reveals oligomers and potential contact surfaces in a G protein-coupled receptor. J. Biol. Chem. 278, 35345-35353.
12. Koshimizu T. A., Tanoue A., Hirasawa A., Yamauchi J., and Tsujimoto G. (2003) Recent advances in alpha1-adrenoceptor pharmacology. Pharmacol. Ther. 98, 235-244.
13. Lee S. P., O'Dowd B. F., Rajaram R. D., Nguyen T., and George S. R. (2003) D2 dopamine receptor homodimerization is mediated by multiple sites of interaction, including an intermolecular interaction involving transmembrane domain 4. Biochemistry 42, 11023-11031.
14. Liang Y., Fotiadis D., Filipek S., Saperstein D. A., Palczewski K., and Engel A. (2003) Organization of the G protein-coupled receptors rhodopsin and opsin in native membranes. J. Biol. Chem. 278, 21655-21662.
15. Margeta-Mitrovic M. (2002) Assembly-dependent trafficking assays in the detection of receptor-receptor interactions. Methods 27, 311-317.
16. Mercier J. F., Salahpour A., Angers S., Breit A., and Bouvier M. (2002) Quantitative assessment of beta 1- and beta 2-adrenergic receptor homo- and heterodimerization by bioluminescence resonance energy transfer. J. Biol. Chem. 277, 44925-44931.
17. Milligan G. (2004) G protein-coupled receptor dimerization: function and ligand pharmacology. Mol. Pharmacol. 66, 1-7.
18. Milligan G. and White J. H. (2001) Protein-protein interactions at G-protein-coupled receptors. Trends Pharmacol. Sci. 22, 513-518.
19. Milligan G., Lopez-Gimenez J. F., Wilson S., and Carrillo J. (2004) Selectivity in the oligomerisation of G protein-coupled receptors. Semin. Cell Develop. Biol. 15, 263-268.
20. Morris D. P., Price R. R., Smith M. P., Lei B., and Schwinn D. A. (2004) Cellular trafficking of human 1a-adrenergic receptors is continuous and primarily agonist-independent. Mol. Pharmacol. 66, 843-854.
21. Piascik M.T. and Perez D.M. (2001) Alpha1-adrenergic receptors: new insights and directions. J. Pharmacol. Exp. Ther. 298, 403-410.
22. 1L-adrenoceptor. Mol. Pharmacol. 66, 228-239.
23. Ramsay D., Kellett E., McVey M., Rees S., and Milligan G. (2002) Homo- and hetero-oligomeric interactions between G-protein-coupled receptors in living cells monitored by two variants of bioluminescence resonance energy transfer (BRET): hetero-oligomers between receptor subtypes form more efficiently than between less closely related sequences. Biochem. J. 365, 429-440.
24. Rodriguez-Frade J. M., Mellado M., and Martinez-A.C. (2001) Chemokine receptor dimerization: two are better than one. Trends Immunol. 22, 612-617.
25. Salahpour A., Angers S., Mercier J. F., Lagace M., Marullo S., and Bouvier M. (2004) Homodimerization of the beta 2-adrenergic receptor as a pre-requisite for cell surface targeting. J. Biol. Chem. 279, 33390-33397.
26. Schwappach B., Zerangue N., Jan Y. N., and Jan L. Y. (2000) Molecular basis for K(ATP) assembly: transmembrane interactions mediate association of a K+ channel with an ABC transporter. Neuron 26, 155-167.
27. 1b-adrenergic receptor subtypes. J. Biol. Chem. 278, 40239-40251.
28. Trettel F., Di Bartolomeo .S., Lauro C., Catalano M., Ciotti M. T., and Limatola C. (2003) Ligand-independent CXCR2 dimerization. J. Biol. Chem. 278, 40980-40988.
29. Uberti M. A., Hall R. A., and Minneman K. P. (2003) Subtype-specific dimerization of alpha 1-adrenoceptors: effects on receptor expression and pharmaco-logical properties. Mol. Pharmacol. 64, 1379-1390.